These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modeling and alanine scanning mutagenesis studies of recombinant pokeweed antiviral protein. Rajamohan F, Pugmire MJ, Kurinov IV, Uckun FM. J Biol Chem; 2000 Feb 04; 275(5):3382-90. PubMed ID: 10652330 [Abstract] [Full Text] [Related]
6. Binding interactions between the active center cleft of recombinant pokeweed antiviral protein and the alpha-sarcin/ricin stem loop of ribosomal RNA. Rajamohan F, Mao C, Uckun FM. J Biol Chem; 2001 Jun 29; 276(26):24075-81. PubMed ID: 11313342 [Abstract] [Full Text] [Related]
7. The action of pokeweed antiviral protein and ricin A-chain on mutants in the alpha-sarcin loop of Escherichia coli 23S ribosomal RNA. Marchant A, Hartley MR. J Mol Biol; 1995 Dec 15; 254(5):848-55. PubMed ID: 7500355 [Abstract] [Full Text] [Related]
11. Active center cleft residues of pokeweed antiviral protein mediate its high-affinity binding to the ribosomal protein L3. Rajamohan F, Ozer Z, Mao C, Uckun FM. Biochemistry; 2001 Aug 07; 40(31):9104-14. PubMed ID: 11478877 [Abstract] [Full Text] [Related]
12. Analysis of active site residues of the antiviral protein from summer leaves from Phytolacca americana by site-directed mutagenesis. Poyet JL, Hoeveler A, Jongeneel CV. Biochem Biophys Res Commun; 1998 Dec 30; 253(3):582-7. PubMed ID: 9918771 [Abstract] [Full Text] [Related]
14. Evidence for retro-translocation of pokeweed antiviral protein from endoplasmic reticulum into cytosol and separation of its activity on ribosomes from its activity on capped RNA. Parikh BA, Baykal U, Di R, Tumer NE. Biochemistry; 2005 Feb 22; 44(7):2478-90. PubMed ID: 15709760 [Abstract] [Full Text] [Related]
15. High resolution X-ray structure and potent anti-HIV activity of recombinant dianthin antiviral protein. Kurinov IV, Rajamohan F, Uckun FM. Arzneimittelforschung; 2004 Feb 22; 54(10):692-702. PubMed ID: 15553110 [Abstract] [Full Text] [Related]
16. Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus. Uckun FM, Bellomy K, O'Neill K, Messinger Y, Johnson T, Chen CL. J Pharmacol Exp Ther; 1999 Dec 22; 291(3):1301-7. PubMed ID: 10565855 [Abstract] [Full Text] [Related]
17. A C-terminal deletion mutant of pokeweed antiviral protein inhibits programmed +1 ribosomal frameshifting and Ty1 retrotransposition without depurinating the sarcin/ricin loop of rRNA. Hudak KA, Hammell AB, Yasenchak J, Tumer NE, Dinman JD. Virology; 2001 Jan 05; 279(1):292-301. PubMed ID: 11145910 [Abstract] [Full Text] [Related]
18. A novel interaction of pokeweed antiviral protein with translation initiation factors 4G and iso4G: a potential indirect mechanism to access viral RNAs. Wang M, Hudak KA. Nucleic Acids Res; 2006 Jan 05; 34(4):1174-81. PubMed ID: 16493141 [Abstract] [Full Text] [Related]
19. High resolution X-ray structure of potent anti-HIV pokeweed antiviral protein-III. Kurinov IV, Uckun FM. Biochem Pharmacol; 2003 May 15; 65(10):1709-17. PubMed ID: 12754107 [Abstract] [Full Text] [Related]
20. Effect of N-terminal deletions on the activity of pokeweed antiviral protein expressed in E. coli. Xu J, Meng AX, Hefferon KL, Ivanov IG, Abouhaidar MG. Biochimie; 1998 Dec 15; 80(12):1069-76. PubMed ID: 9924987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]